Your browser doesn't support javascript.
loading
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.
Scott, Jacob G; Sedor, Geoffrey; Ellsworth, Patrick; Scarborough, Jessica A; Ahmed, Kamran A; Oliver, Daniel E; Eschrich, Steven A; Kattan, Michael W; Torres-Roca, Javier F.
Affiliation
  • Scott JG; Translational Hematology and Oncology Research, Radiation Oncology Department, Cleveland Clinic, Cleveland, OH, USA; Systems Biology and Bioinformatics, Case Western Reserve University, Cleveland, OH, USA.
  • Sedor G; School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
  • Ellsworth P; School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
  • Scarborough JA; Translational Hematology and Oncology Research, Radiation Oncology Department, Cleveland Clinic, Cleveland, OH, USA; Systems Biology and Bioinformatics, Case Western Reserve University, Cleveland, OH, USA.
  • Ahmed KA; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA.
  • Oliver DE; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA.
  • Eschrich SA; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA.
  • Kattan MW; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
  • Torres-Roca JF; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA. Electronic address: Javier.torresroca@moffitt.org.
Lancet Oncol ; 22(9): 1221-1229, 2021 09.
Article in En | MEDLINE | ID: mdl-34363761

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Dosage / Radiation Genomics / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Dosage / Radiation Genomics / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: United States